FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Donohue

Research Profile

Disorders

Procedures

Anatomy

Retroperitoneal Space

Concepts & Ideas

Chemicals & Drugs

Biological Tumor Markers

Co-author Network

Publications

TOP 3
Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
Stephen D W Beck; Richard S Foster; Richard Bihrle; John P Donohue; Lawrence H Einhorn
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Stephen D W Beck; Matthew D Peterson; Richard Bihrle; John P Donohue; Richard S Foster
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Donohue (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
The Journal of urology 2009;181(6):2526-32.
2007: Stephen D W Beck; Richard S Foster; Richard Bihrle; John P Donohue; Lawrence H Einhorn
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Cancer 2007;110(6):1235-40.
2007: Stephen D W Beck; Matthew D Peterson; Richard Bihrle; John P Donohue; Richard S Foster
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
The Journal of urology 2007;178(2):504-6; discussion 506.
2007: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
The Urologic clinics of North America 2007;34(2):219-25; abstract ix-x.
2007: Stephen D W Beck; Richard S Foster; Richard Bihrle; John P Donohue
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Urology 2007;69(3):557-9.
2007: Stephen D W Beck; Liang Cheng; Richard Bihrle; John P Donohue; Richard S Foster
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
The Journal of urology 2007;177(3):944-6.
2007: Niels-Erik B Jacobsen; Richard S Foster; John P Donohue
Retroperitoneal lymph node dissection in testicular cancer.
Surgical oncology clinics of North America 2007;16(1):199-220.
2005: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.
Urologic oncology 2005;23(6):423-30.
2005: Stephen D W Beck; Richard S Foster; Richard Bihrle; Liang Cheng; John P Donohue
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?
The Journal of urology 2005;174(4 Pt 1):1287-90; discussion 1290.
2005: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6149-56.
2005: Stephen D W Beck; Richard S Foster; Richard Bihrle; Liang Cheng; Thomas M Ulbright; John P Donohue
Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor.
The Journal of urology 2005;174(1):143-5.
2004: Ashraf A Mosharafa; Richard S Foster; Michael O Koch; Richard Bihrle; John P Donohue
Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
The Journal of urology 2004;171(5):1839-41.
2004: Ashraf A Mosharafa; Richard S Foster; Bradley C Leibovich; Thomas M Ulbright; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Histology in mixed germ cell tumors. Is there a favorite pairing?
The Journal of urology 2004;171(4):1471-3.
2003: Ashraf A Mosharafa; Richard S Foster; Richard Bihrle; Michael O Koch; Thomas M Ulbright; Lawrence H Einhorn; John P Donohue
Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Cancer 2003;98(4):753-7.
2003: Ashraf A Mosharafa; Richard S Foster; Bradley C Leibovich; Richard Bihrle; Cynthia Johnson; John P Donohue
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
The Journal of urology 2003;169(6):2126-8.
2003: John P Donohue
Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT).
Urologic oncology 2003;21(2):129-32.
2002: Stephen D W Beck; Richard S Foster; Richard Bihrle; Thomas M Ulbright; Michael O Koch; Gregory R Wahle; Lawrence H Einhorn; John P Donohue
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
The Journal of urology 2002;168(4 Pt 1):1402-4.
2001: Stephen D W Beck; Richard S Foster; Richard Bihrle; Michael O Koch; Gregory R Wahle; John P Donohue
Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
The Journal of urology 2001;165(5):1517-20.
2000: Richard S Foster; BP Hermans; Richard Bihrle; John P Donohue
Clinical stage I pure yolk sac tumor of the testis in adults has different clinical behavior than juvenile yolk sac tumor.
The Journal of urology 2000;164(6):1943-4.
2000: BP Hermans; Christopher J Sweeney; Richard S Foster; L E Einhorn; John P Donohue
Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
The Journal of urology 2000;163(6):1721-4.
2000: Christopher J Sweeney; BP Hermans; Douglas K Heilman; Richard S Foster; John P Donohue; Lawrence H Einhorn
Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):358-62.
1998: BP Hermans; Richard S Foster; Richard Bihrle; S Little; Alan B Sandler; Lawrence H Einhorn; John P Donohue
Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?
The Journal of urology 1998;160(6 Pt 1):2074-7.
1998: Lawrence H Einhorn; John P Donohue
Advanced testicular cancer: update for urologists.
The Journal of urology 1998;160(6 Pt 1):1964-9.
1998: Richard S Foster; John P Donohue
Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?
The Urologic clinics of North America 1998;25(3):479-84.
1998: John P Donohue; Richard S Foster
Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques.
The Urologic clinics of North America 1998;25(3):461-8.
1998: CL Coogan; Richard S Foster; G R Simmons; PG Tognoni; B J Roth; John P Donohue
Bilateral testicular tumors: management and outcome in 21 patients.
Cancer 1998;83(3):547-52.
1998: PG Tognoni; Richard S Foster; P McGraw; Douglas K Heilman; Richard Bihrle; R G Rowland; Gregory R Wahle; Lawrence H Einhorn; John P Donohue; P G Tognini
Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology.
The Journal of urology 1998;159(6):1833-5.
1998: John P Donohue; I Leviovitch; Richard S Foster; J Baniel; PG Tognoni
Integration of surgery and systemic therapy: results and principles of integration.
Seminars in urologic oncology 1998;16(2):65-71.
1998: P A Nash; I Leibovitch; Richard S Foster; Richard Bihrle; R G Rowland; John P Donohue
En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.
The Journal of urology 1998;159(3):707-10.
1998: I Leibovitch; Richard S Foster; K K Kopecky; P Albers; Thomas M Ulbright; John P Donohue
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):261-8.
1997: CL Coogan; Richard S Foster; R G Rowland; Richard Bihrle; E R Smith; Lawrence H Einhorn; B J Roth; John P Donohue
Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
Urology 1997;50(6):957-62.
1997: D J Debono; Douglas K Heilman; Lawrence H Einhorn; John P Donohue
Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1455-64.
1996: C L Coogan; M J Hejase; G R Wahle; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
The Journal of urology 1996;156(5):1656-8.
1996: M J Hejase; John P Donohue; Richard S Foster; Richard Bihrle; C L Coogan; R G Rowland; G R Wahle
Post-chemotherapy resection of nonseminomatous germ cell testicular tumors metastatic to the mediastinum.
The Journal of urology 1996;156(4):1345-8.
1996: P A Nash; C G Schrepferman; R G Rowland; J Young; Richard S Foster; R Birhle; John P Donohue
The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retropubic prostatectomy.
British journal of urology 1996;77(6):856-60.
1996: Richard S Foster; J Baniel; I Leibovitch; M Curran; Richard Bihrle; R Rowland; John P Donohue
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
The Journal of urology 1996;155(6):1943-5.
1996: I Leibovitch; J Baniel; R G Rowland; E R Smith; J K Ludlow; John P Donohue
Malignant testicular neoplasms in immunosuppressed patients.
The Journal of urology 1996;155(6):1938-42.
1996: P A Nash; John P Donohue
Discordance between the site of primary nonseminomatous germ cell tumor of the testis and retroperitoneal metastatic disease secondary to anomalous venous drainage of the testis.
The Journal of urology 1996;155(4):1393-4.
1996: I Leibovitch; J S Little; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors.
The Journal of urology 1996;155(3):952-4.
1996: I Leibovitch; P A Nash; J S Little; Richard S Foster; John P Donohue
Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer.
The Journal of urology 1996;155(3):947-51.
1996: SB Saxman; Craig Nichols; Richard S Foster; J E Messemer; John P Donohue; L H Einhorn
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
The Journal of urology 1996;155(2):587-9.
1996: Peter Albers; Thomas M Ulbright; J Albers; G A Miller; Attilio Orazi; W N Crabtree; J Baniel; T Reister; R A Sidner; Richard S Foster; John P Donohue
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
The Journal of urology 1996;155(2):579-86.
1996: John P Donohue; Richard S Foster; J S Little; Patrick J Loehrer; L E Einhorn
Biology of metastases and its clinical implications: testicular germ-cell tumors.
World journal of urology 1996;14(3):197-203.
1995: L Leibovitch; Richard S Foster; Kenyon K Kopecky; John P Donohue
Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes.
The Journal of urology 1995;154(5):1759-63.
1995: P A Nash; I Leibovitch; John P Donohue
Adrenalectomy via the dorsal approach: a benchmark for laparoscopic adrenalectomy.
The Journal of urology 1995;154(5):1652-4.
1995: J Baniel; Richard S Foster; L H Einhorn; John P Donohue
Late relapse of clinical stage I testicular cancer.
The Journal of urology 1995;154(4):1370-2.
1995: J Baniel; I Leibovitch; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
The Journal of urology 1995;154(4):1373-5.
1995: I Leibovitch; J Baniel; Richard S Foster; John P Donohue
The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer.
The Journal of urology 1995;154(3):935-9.
1995: I Leibovitch; R G Rowland; B Goldwasser; John P Donohue
Incidental appendectomy during urological surgery.
The Journal of urology 1995;154(3):1110-2.
1995: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1599-604.
1995: Peter Albers; Thomas M Ulbright; J Albers; G A Miller; Richard S Foster; John P Donohue
[New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
Der Urologe. Ausg. A 1995;34(4):316-23.
1995: I Leibovitch; R G Rowland; J S Little; Richard S Foster; Richard Bihrle; John P Donohue
Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings.
Urology 1995;46(1):78-80.
1995: J Baniel; B J Roth; Richard S Foster; John P Donohue
Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors.
Cancer 1995;75(12):2897-903.
1995: I Leibovitch; Richard S Foster; J L Wass; R G Rowland; Richard Bihrle; J S Little; Kenyon K Kopecky; John P Donohue
Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma.
The Journal of urology 1995;153(6):1866-9.
1995: Peter Albers; Attilio Orazi; Thomas M Ulbright; G A Miller; J H Haidar; John P Donohue; Richard S Foster
Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(5):492-7.
1995: J Baniel; Richard S Foster; John P Donohue
Surgical anatomy of the lumbar vessels: implications for retroperitoneal surgery.
The Journal of urology 1995;153(5):1422-5.
1995: I Leibovitch; Richard S Foster; Thomas M Ulbright; John P Donohue
Adult primary pure teratoma of the testis. The Indiana experience.
Cancer 1995;75(9):2244-50.
1995: J Baniel; Richard S Foster; R Gonin; J E Messemer; John P Donohue; L H Einhorn
Late relapse of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1170-6.
1995: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Complications of post-chemotherapy retroperitoneal lymph node dissection.
The Journal of urology 1995;153(3 Pt 2):976-80.
1995: Peter Albers; G A Miller; Attilio Orazi; Thomas M Ulbright; J Albers; John P Donohue; Richard S Foster
Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Cancer 1995;75(3):844-50.
1995: C de Riese; W N Crabtree; W de Riese; J A Jones; J Pastor; Gerald Haupt; Richard S Foster; John P Donohue; Theodor Senge
Impact of the preparation technique on DNA content measured by image analysis in early stage human testis cancer.
International urology and nephrology 1995;27(5):603-13.
1995: Peter Albers; W T DeRiese; Thomas M Ulbright; John P Donohue; Richard S Foster
Prognostic factors in patients with pathological stage I non-seminomatous testicular germ cell tumors and tumor recurrence during follow-up.
Urological research 1995;23(4):211-3.
1995: John P Donohue; J A Thornhill; Richard S Foster; Richard Bihrle; R G Rowland; L H Einhorn
The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).
The Journal of urology 1995;153(1):85-9.
1995: Peter Albers; J Albers; O W Cummings; M Boris; John P Donohue; Richard S Foster
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):848-9.
1994: John P Donohue; Richard S Foster
Management of retroperitoneal recurrences. Seminoma and nonseminoma.
The Urologic clinics of North America 1994;21(4):761-72.
1994: J S Little; Richard S Foster; Thomas M Ulbright; John P Donohue
Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy.
The Journal of urology 1994;152(4):1144-9.
1994: Richard S Foster; A McNulty; L R Rubin; R Bennett; R G Rowland; G W Sledge; Richard Bihrle; John P Donohue
The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection.
The Journal of urology 1994;152(4):1139-42; discussion 1142-3.
1994: W T de Riese; Peter Albers; E B Walker; Thomas M Ulbright; W N Crabtree; T Reister; Richard S Foster; John P Donohue
Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
Cancer 1994;74(4):1335-41.
1994: G R Wahle; Richard S Foster; Richard Bihrle; R G Rowland; R M Bennett; John P Donohue
Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma.
The Journal of urology 1994;152(2 Pt 1):428-30.
1994: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Complications of primary retroperitoneal lymph node dissection.
The Journal of urology 1994;152(2 Pt 1):424-7.
1994: Richard S Foster; Richard Bihrle; N Sanghvi; John P Donohue
High-intensity focused ultrasound for the treatment of benign prostatic hypertrophy.
Seminars in urology 1994;12(3):200-4.
1994: Richard Bihrle; Richard S Foster; N T Sanghvi; John P Donohue; P J Hood
High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience.
The Journal of urology 1994;151(5):1271-5.
1994: Richard Bihrle; Richard S Foster; N T Sanghvi; F J Fry; John P Donohue
High-intensity focused ultrasound in the treatment of prostatic tissue.
Urology 1994;43(2 Suppl):21-6.
1994: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer.
World journal of urology 1994;12(3):139-42.
1994: Richard S Foster; A McNulty; L R Rubin; R Bennett; R G Rowland; G W Sledge; Richard Bihrle; John P Donohue
Fertility considerations in nerve-sparing retroperitoneal lymph-node dissection.
World journal of urology 1994;12(3):136-8.
1994: Peter Albers; W deRiese; E B Walker; Thomas M Ulbright; W N Crabtree; T Reister; Richard S Foster; John P Donohue
Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection.
World journal of urology 1994;12(3):120-4.
1994: Thomas M Ulbright; Attilio Orazi; W de Riese; C de Riese; J E Messemer; Richard S Foster; John P Donohue; J N Eble
The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(1):64-8.
1994: W de Riese; E B Walker; C de Riese; Thomas M Ulbright; W N Crabtree; J Messemer; J A Jones; A Hinkel; Richard S Foster; John P Donohue
Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors.
Urological research 1994;22(4):213-20.
1994: J S Little; Richard S Foster; Thomas M Ulbright; John P Donohue
Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy.
World journal of urology 1994;12(4):200-6.
1994: John P Donohue; E P Fox; S D Williams; Patrick J Loehrer; Thomas M Ulbright; L H Einhorn; T D Weathers
Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.
World journal of urology 1994;12(4):190-5.
1994: John P Donohue; J A Thornhill; Richard S Foster; Richard Bihrle
Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II.
World journal of urology 1994;12(4):187-9.
1994: John P Donohue; J A Thornhill; Richard S Foster; Richard Bihrle
Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava.
World journal of urology 1994;12(4):182-6.
1994: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.
World journal of urology 1994;12(4):170-6; discussion 177.
1994: Richard S Foster; Richard Bihrle; N T Sanghvi; John P Donohue; F J Fry
High intensity focused ultrasound treatment of human BPH.
Progress in clinical and biological research 1994;386():463-71.
1994: Richard S Foster; Richard Bihrle; J S Little; R G Rowland; John P Donohue
Stage II nonseminomatous germ-cell testicular tumors--the Indiana experience and risk-benefit analysis.
World journal of urology 1994;12(3):143-6; discussion 147.
1993: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer.
The Journal of urology 1993;150(5 Pt 1):1422-4.
1993: P E Gleason; M H Weinberger; J H Pratt; Richard Bihrle; J Dugan; D Eller; John P Donohue
Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia.
The Journal of urology 1993;150(5 Pt 1):1365-8.
1993: E P Fox; T D Weathers; S D Williams; Patrick J Loehrer; Thomas M Ulbright; John P Donohue; L H Einhorn
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1294-9.
1993: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.
British journal of urology 1993;71(3):326-35.
1993: Richard S Foster; John P Donohue
Nerve-sparing retroperitoneal lymphadenectomy.
The Urologic clinics of North America 1993;20(1):117-25.
1993: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.
The Journal of urology 1993;149(2):237-43.
1993: B R Murphy; E S Breeden; John P Donohue; J Messemer; W Walsh; B J Roth; L H Einhorn
Surgical salvage of chemorefractory germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):324-9.
1993: John P Donohue
Nerve-sparing retroperitoneal lymphadenectomy for testis cancer. Evolution of surgical templates for low-stage disease.
European urology 1993;23 Suppl 2():44-6.
1993: Richard S Foster; R Bennett; Richard Bihrle; John P Donohue
A preliminary report: postoperative fertility assessment in nerve-sparing RPLND patients.
European urology 1993;23(1):165-7; discussion 168.
1993: John P Donohue
Unsolved problems in testis cancer.
European urology 1993;23 Suppl 2():57-9.
1993: Richard S Foster; Richard Bihrle; N T Sanghvi; F J Fry; John P Donohue
High-intensity focused ultrasound in the treatment of prostatic disease.
European urology 1993;23 Suppl 1():29-33.
1993: Richard S Foster; Richard Bihrle; N Sanghvi; F Fry; K Kopecky; J Regan; J Eble; C Hennige; L V Hennige; John P Donohue
Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound.
European urology 1993;23(2):330-6.
1992: Richard S Foster; John P Donohue
Surgical treatment of clinical stage A nonseminomatous testis cancer.
Seminars in oncology 1992;19(2):166-70.
1991: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Resection of the inferior vena cava or intraluminal vena caval tumor thrombectomy during retroperitoneal lymph node dissection for metastatic germ cell cancer: indications and results.
The Journal of urology 1991;146(2):346-9.
1991: Richard S Foster; L R Rubin; A McNulty; Richard Bihrle; John P Donohue
Detection of antisperm-antibodies in patients with primary testicular cancer.
International journal of andrology 1991;14(3):179-85.
1991: Richard S Foster; John P Donohue; Richard Bihrle
Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.
Urologia internationalis 1991;46(3):294-7.
1990: John P Donohue; Richard S Foster; R G Rowland; Richard Bihrle; J Jones; G Geier
Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation.
The Journal of urology 1990;144(2 Pt 1):287-91; discussion 291-2.
1990: John P Donohue; H Schraffordt Koops; W F Hendry; F M DeBruyne
Surgery in advanced disease for testicular cancer.
Progress in clinical and biological research 1990;357():305-12.
1990: John P Donohue
Overview: treatment of local regional disease.
Progress in clinical and biological research 1990;350():283-93.
1990: Thomas M Ulbright; Helen Michael; Patrick J Loehrer; John P Donohue
Spindle cell tumors resected from male patients with germ cell tumors. A clinicopathologic study of 14 cases.
Cancer 1990;65(1):148-56.
1988: R G Rowland; John P Donohue
Testicular cancer: innovations in diagnosis and treatment.
Seminars in urology 1988;6(3):223-32.
1988: Richard Bihrle; John P Donohue; Richard S Foster
Complications of retroperitoneal lymph node dissection.
The Urologic clinics of North America 1988;15(2):237-42.
1987: John P Donohue; R G Rowland; K Kopecky; C P Steidle; G Geier; K G Ney; L Einhorn; S Williams; P Loehrer
Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer.
The Journal of urology 1987;137(6):1176-9.